Andrews NJ - Search Results

1

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Miller E, et al. Among authors: andrews nj. Vaccine. 2011 Nov 15;29(49):9127-31. doi: 10.1016/j.vaccine.2011.09.112. Epub 2011 Oct 5. Vaccine. 2011. PMID: 21983361

2

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Taylor B, et al. BMJ. 2002 Feb 16;324(7334):393-6. doi: 10.1136/bmj.324.7334.393. BMJ. 2002. PMID: 11850369 Free PMC article.

3

Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants.

Longworth E, Borrow R, Goldblatt D, Balmer P, Dawson M, Andrews N, Miller E, Cartwright K. Longworth E, et al. Vaccine. 2002 Jun 7;20(19-20):2592-6. doi: 10.1016/s0264-410x(02)00151-2. Vaccine. 2002. PMID: 12057617

4

Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.

Burrage M, Robinson A, Borrow R, Andrews N, Southern J, Findlow J, Martin S, Thornton C, Goldblatt D, Corbel M, Sesardic D, Cartwight K, Richmond P, Miller E. Burrage M, et al. Infect Immun. 2002 Sep;70(9):4946-54. doi: 10.1128/IAI.70.9.4946-4954.2002. Infect Immun. 2002. PMID: 12183540 Free PMC article. Clinical Trial.

5

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

Borrow R, Goldblatt D, Andrews N, Southern J, Ashton L, Deane S, Morris R, Cartwright K, Miller E. Borrow R, et al. J Infect Dis. 2002 Nov 1;186(9):1353-7. doi: 10.1086/344324. Epub 2002 Oct 8. J Infect Dis. 2002. PMID: 12402208

6

Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era.

Trotter C, Borrow R, Andrews N, Miller E. Trotter C, et al. Vaccine. 2003 Mar 7;21(11-12):1094-8. doi: 10.1016/s0264-410x(02)00630-8. Vaccine. 2003. PMID: 12559785

7

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E. Knowles WA, et al. J Med Virol. 2003 Sep;71(1):115-23. doi: 10.1002/jmv.10450. J Med Virol. 2003. PMID: 12858417

8

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.

Andrews N, Borrow R, Miller E. Andrews N, et al. Clin Diagn Lab Immunol. 2003 Sep;10(5):780-6. doi: 10.1128/cdli.10.5.780-786.2003. Clin Diagn Lab Immunol. 2003. PMID: 12965904 Free PMC article.

9

Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.

Borrow R, Goldblatt D, Finn A, Southern J, Ashton L, Andrews N, Lal G, Riley C, Rahim R, Cartwright K, Allan G, Miller E. Borrow R, et al. Infect Immun. 2003 Oct;71(10):5549-55. doi: 10.1128/IAI.71.10.5549-5555.2003. Infect Immun. 2003. PMID: 14500473 Free PMC article. Clinical Trial.

10

Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.

Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Andrews N, et al. Pediatrics. 2004 Sep;114(3):584-91. doi: 10.1542/peds.2003-1177-L. Pediatrics. 2004. PMID: 15342825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters